|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US6964946B1
(en)
*
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6727280B2
(en)
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
GB9715759D0
(en)
*
|
1997-07-26 |
1997-10-01 |
Danbiosyst Uk |
New emulsion formulations
|
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
|
NZ512287A
(en)
*
|
1998-12-11 |
2002-12-20 |
Pharmasolutions Inc |
Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
|
|
WO2000040219A1
(en)
|
1998-12-30 |
2000-07-13 |
Dexcel Ltd. |
Dispersible concentrate for the delivery of cyclosporin
|
|
US6045826A
(en)
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
WO2000059488A2
(en)
*
|
1999-04-02 |
2000-10-12 |
Washington State University Research Foundation |
Enhanced tissue and subcellular delivery of vitamin e compounds
|
|
US6632443B2
(en)
|
2000-02-23 |
2003-10-14 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US20080070981A1
(en)
|
2000-02-23 |
2008-03-20 |
Henryk Borowy-Borowski |
Water-soluble compositions of bioactive lipophilic compounds
|
|
HUP0203903A3
(en)
*
|
1999-04-13 |
2004-09-28 |
Leo Pharm Prod Ltd |
Solubilized pharmaceutical composition for parenteral administration and its use
|
|
KR100754352B1
(ko)
*
|
1999-05-24 |
2007-08-31 |
소너스파머슈티칼즈인코포레이티드 |
난용성 약물용 에멀젼 부형제의 제조방법
|
|
CA2373994A1
(en)
*
|
1999-05-24 |
2000-11-30 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
EP1479382A1
(en)
*
|
1999-06-18 |
2004-11-24 |
IVAX Research, Inc. |
Oral pharmaceutical compositions containing taxanes and methods for treatment employing the same
|
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
AU7719100A
(en)
|
1999-09-27 |
2001-04-30 |
Panayiotis Constantinides |
Compositions of tocol-soluble therapeutics
|
|
US6828346B2
(en)
*
|
1999-10-25 |
2004-12-07 |
Supergen, Inc. |
Methods for administration of paclitaxel
|
|
US6136846A
(en)
|
1999-10-25 |
2000-10-24 |
Supergen, Inc. |
Formulation for paclitaxel
|
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
DE60111352T2
(de)
*
|
2000-01-20 |
2006-05-04 |
Supratek Pharma, Inc., Montreal |
Podophyllotoxin-zusammensetzungen
|
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
|
US8618085B2
(en)
*
|
2000-04-28 |
2013-12-31 |
Koasn Biosciences Incorporated |
Therapeutic formulations of desoxyepothilones
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
GB0016876D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Novel formulation
|
|
JP2004504342A
(ja)
*
|
2000-07-24 |
2004-02-12 |
ファルマシア・アンド・アップジョン・カンパニー |
極めて水不溶性の脂肪親和性薬剤用の自己乳化性ドラッグデリバリーシステム
|
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
WO2002026208A2
(en)
*
|
2000-09-27 |
2002-04-04 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
CN1262274C
(zh)
*
|
2000-11-14 |
2006-07-05 |
生命健康科学有限公司 |
磷酸盐衍生物复合物
|
|
AUPR549901A0
(en)
|
2001-06-06 |
2001-07-12 |
Vital Health Sciences Pty Ltd |
Topical formulation containing tocopheryl phosphates
|
|
EP1343492B1
(en)
*
|
2000-11-22 |
2006-02-01 |
Rxkinetix, Inc. |
Treatment of mucositis
|
|
US6919370B2
(en)
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
|
EP1345589B1
(en)
*
|
2000-11-29 |
2007-06-27 |
Lyotropic Therapeutics, Inc. |
Solvent systems for pharmaceutical agents
|
|
WO2002058689A1
(en)
*
|
2000-12-05 |
2002-08-01 |
Childrens Hospital Los Angeles |
Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same
|
|
IN188917B
(enExample)
*
|
2000-12-07 |
2002-11-23 |
Bharat Surums & Vaccines Ltd |
|
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
|
BR0211673A
(pt)
|
2001-07-27 |
2004-07-13 |
Vital Health Sciences Pty Ltd |
Terapia dermal utilizando derivados de fosfato de agentes de transferência de elétrons
|
|
AUPR684801A0
(en)
*
|
2001-08-06 |
2001-08-30 |
Vital Health Sciences Pty Ltd |
Supplement therapy
|
|
US20030099674A1
(en)
*
|
2001-08-11 |
2003-05-29 |
Chen Andrew X. |
Lyophilized injectable formulations containing paclitaxel or other taxoid drugs
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
CN1558755A
(zh)
|
2001-09-26 |
2004-12-29 |
���ع��ʹ�˾ |
通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
|
|
US6858227B1
(en)
|
2001-11-21 |
2005-02-22 |
Sonus Pharmaceuticals, Inc. |
Vitamin E conjugates
|
|
AU2002357012A1
(en)
*
|
2001-11-27 |
2003-06-10 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
|
MXPA04005260A
(es)
*
|
2001-12-03 |
2005-03-23 |
Novacea Inc |
Composiciones farmaceuticas que comprenden compuestos activos de vitamina d.
|
|
US20060078618A1
(en)
*
|
2001-12-11 |
2006-04-13 |
Constantinides Panayiotis P |
Lipid particles and suspensions and uses thereof
|
|
ATE487456T1
(de)
*
|
2001-12-13 |
2010-11-15 |
Vital Health Sciences Pty Ltd |
Transdermaler transport von verbindungen
|
|
JP4598399B2
(ja)
|
2002-02-04 |
2010-12-15 |
エラン ファーマ インターナショナル，リミティド |
表面安定剤としてリゾチームを有するナノ粒子組成物
|
|
US6683194B2
(en)
*
|
2002-02-05 |
2004-01-27 |
Sonus Pharmaceuticals, Inc. |
Tocopherol derivatives
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
CA2476589C
(en)
*
|
2002-02-27 |
2014-02-25 |
Pharmain, Ltd. |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
ES2283756T3
(es)
*
|
2002-03-01 |
2007-11-01 |
Novagali Pharma Sa |
Sistemas autoemulsionantes de administracion de farmaco para taxoides.
|
|
EP1340497A1
(en)
*
|
2002-03-01 |
2003-09-03 |
Novagali Sas |
Self emulsifying drug delivery systems for poorly soluble drugs
|
|
US6825229B2
(en)
|
2002-03-07 |
2004-11-30 |
Blanchette Rockefeller Neurosciences Institute |
Methods for Alzheimer's Disease treatment and cognitive enhancement
|
|
US20050065205A1
(en)
*
|
2002-03-07 |
2005-03-24 |
Daniel Alkon |
Methods for Alzheimer's disease treatment and cognitive enhance
|
|
US20080004332A1
(en)
*
|
2002-03-07 |
2008-01-03 |
Alkon Daniel L |
Methods for alzheimer's disease treatment and cognitive enhancement
|
|
ATE343376T1
(de)
*
|
2002-03-20 |
2006-11-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
|
KR20100110378A
(ko)
|
2002-05-24 |
2010-10-12 |
안지오테크 인터내셔날 아게 |
의료용 임플란트를 피복하기 위한 조성물 및 방법
|
|
FR2840614B1
(fr)
*
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
PT1553940E
(pt)
*
|
2002-07-30 |
2008-05-09 |
Wyeth Corp |
Formulações parentéricas contendo um hidroxi-éster de rapamicina
|
|
AU2002950713A0
(en)
|
2002-08-09 |
2002-09-12 |
Vital Health Sciences Pty Ltd |
Carrier
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
DE60330703D1
(de)
|
2002-11-07 |
2010-02-04 |
Kosan Biosciences Inc |
Trans-9,10-dehydroepothilon c und d, analoga davon und verfahren zu deren herstellung
|
|
KR100507771B1
(ko)
*
|
2002-11-08 |
2005-08-17 |
한미약품 주식회사 |
난용성 감기약 활성 성분의 경구투여용 조성물 및 그의제조 방법
|
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
LT1585548T
(lt)
*
|
2002-12-09 |
2018-09-25 |
Abraxis Bioscience, Llc |
Farmakologinių agentų kompozicijos ir įvedimo būdai
|
|
US20040115287A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Lipocine, Inc. |
Hydrophobic active agent compositions and methods
|
|
KR100502821B1
(ko)
|
2002-12-26 |
2005-07-22 |
이호영 |
구리산화물 또는 구리 나노와이어로 이루어진 전자방출팁의 저온 형성 방법 및 이 방법에 의해 제조된 전자방출팁을 포함하는 디스플레이 장치 또는 광원
|
|
ES2376875T3
(es)
|
2003-02-14 |
2012-03-20 |
Children's Hospital & Research Center At Oakland |
Vehículo de administración de fármacos lipofílicos y métodos de utilización del mismo
|
|
US20050196370A1
(en)
*
|
2003-03-18 |
2005-09-08 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
|
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
US20060251685A1
(en)
*
|
2003-03-18 |
2006-11-09 |
Zhi-Jian Yu |
Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
|
|
WO2004091506A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Ivax Research, Inc. |
Taxane-based compositions and methods of use
|
|
US7485671B2
(en)
|
2003-05-16 |
2009-02-03 |
Velocys, Inc. |
Process for forming an emulsion using microchannel process technology
|
|
JP4611989B2
(ja)
|
2003-05-16 |
2011-01-12 |
ヴェロシス，インク． |
マイクロチャネルプロセス技術を用いてエマルジョンを作製するプロセス
|
|
US7691838B2
(en)
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
EP1498120A1
(en)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Semi-solid formulations for the oral administration of taxoids
|
|
DE602004014624D1
(de)
*
|
2003-08-29 |
2008-08-07 |
Yissum Res Dev Co |
Selbst-nanoemulgierende ölige formulierung zur verabreichung von schwer wasserlöslichen arzneimitteln
|
|
EP1510206A1
(en)
*
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
|
US20050074444A1
(en)
*
|
2003-10-01 |
2005-04-07 |
Papas Andreas M. |
Coenzyme Q10 treatment for cystic fibrosis
|
|
US20050107465A1
(en)
*
|
2003-10-01 |
2005-05-19 |
Papas Andreas M. |
Composition for treating inflammatory bowel disease
|
|
KR100703872B1
(ko)
*
|
2003-10-10 |
2007-04-09 |
주식회사 삼양사 |
양친성 블록 공중합체 및 이를 포함하는 약물 전달용고분자 조성물
|
|
US7311901B2
(en)
*
|
2003-10-10 |
2007-12-25 |
Samyang Corporation |
Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery
|
|
CN100471886C
(zh)
*
|
2003-10-10 |
2009-03-25 |
株式会社三养社 |
两亲嵌段共聚物以及包含它的用于给药的聚合组合物
|
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
KR20060110872A
(ko)
*
|
2003-10-29 |
2006-10-25 |
소너스파머슈티칼즈인코포레이티드 |
토코페롤 변성 치료제 약물 화합물
|
|
US20080045559A1
(en)
*
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
|
US20050096365A1
(en)
*
|
2003-11-03 |
2005-05-05 |
David Fikstad |
Pharmaceutical compositions with synchronized solubilizer release
|
|
TWI350183B
(en)
*
|
2003-12-31 |
2011-10-11 |
Ind Tech Res Inst |
A liposome and a preparation method
|
|
US20050158329A1
(en)
*
|
2004-01-21 |
2005-07-21 |
Ghosh Swapan K. |
Novel phytol derived immunoadjuvants and their use in vaccine formulations
|
|
ATE495730T1
(de)
*
|
2004-03-03 |
2011-02-15 |
Vital Health Sciences Pty Ltd |
Alkaloid-formulierungen
|
|
US20050209315A1
(en)
*
|
2004-03-20 |
2005-09-22 |
Papas Andreas M |
Bioavailable nutritional supplement and method of treatment of malabsorption
|
|
US7989490B2
(en)
|
2004-06-02 |
2011-08-02 |
Cordis Corporation |
Injectable formulations of taxanes for cad treatment
|
|
US8003122B2
(en)
*
|
2004-03-31 |
2011-08-23 |
Cordis Corporation |
Device for local and/or regional delivery employing liquid formulations of therapeutic agents
|
|
US20050220866A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Dr. Reddy's Laboratories Limited |
Novel capsule formulations of etoposide for oral use
|
|
KR20050099311A
(ko)
*
|
2004-04-09 |
2005-10-13 |
에이엔에이치 케어연구소(주) |
주사제용 항암제 조성물
|
|
US20050226932A1
(en)
*
|
2004-04-09 |
2005-10-13 |
Samyang Corporation |
Pharmaceutical formulations for itraconazole
|
|
WO2005112977A2
(en)
*
|
2004-04-23 |
2005-12-01 |
Pharmain, Ltd. |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
TW201207390A
(en)
|
2004-05-18 |
2012-02-16 |
Brni Neurosciences Inst |
Method for screening agent for antidepressant activity
|
|
KR100582604B1
(ko)
|
2004-06-16 |
2006-05-23 |
보람제약주식회사 |
항산화제를 포함한 이부프로펜 및 덱시부프로펜의마이크로 에멀젼과 이를 이용한 투명 액제 및 투명연질캡슐 제제
|
|
RU2007107359A
(ru)
*
|
2004-07-28 |
2008-09-10 |
ЭсДи ФАРМАСЬЮТИКАЛЗ, ИНК. (US) |
Стабильная инъецируемая композиция альфа-токоферилсукцината, его аналогов и солей
|
|
US20090004166A1
(en)
*
|
2004-08-03 |
2009-01-01 |
Simon Michael West |
Carrier For Enternal Administration
|
|
KR100623013B1
(ko)
*
|
2004-09-04 |
2006-09-19 |
김영대 |
나노에멀션, 그의 용도 및 제조방법
|
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
US20060165769A1
(en)
*
|
2004-09-30 |
2006-07-27 |
Hyatt John A |
Pharmaceutical formulations containing vitamin E TPGS molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
|
|
US20080038316A1
(en)
*
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
JP5643474B2
(ja)
|
2004-10-01 |
2014-12-17 |
ヴェロシス，インク． |
マイクロチャネルプロセス技術を用いる多相混合プロセス
|
|
WO2006047579A2
(en)
*
|
2004-10-26 |
2006-05-04 |
Yasoo Health, Inc. |
Vitamin e tpgs fluid concentrate comprising a low percentage of water
|
|
WO2006057895A2
(en)
*
|
2004-11-17 |
2006-06-01 |
Velocys Inc. |
Process for making or treating an emulsion using microchannel technology
|
|
GT200500310A
(es)
|
2004-11-19 |
2006-06-19 |
|
Compuestos organicos
|
|
US20060147518A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Pierre Fabre Medicament |
Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
|
|
JP4877899B2
(ja)
*
|
2005-01-25 |
2012-02-15 |
学校法人近畿大学 |
薬物徐放出性球状微粒子及びその製造方法
|
|
US20090239827A1
(en)
*
|
2005-03-03 |
2009-09-24 |
Esra Ogru |
Compounds having lipid lowering properties
|
|
US20060222716A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Joseph Schwarz |
Colloidal solid lipid vehicle for pharmaceutical use
|
|
CA2603987A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Wisconsin Alumni Research Foundation |
Micelle composition of polymer and passenger drug
|
|
US20060240051A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Singleton Andy H |
Eutectic blends containing a water soluble vitamin derivative
|
|
EP1874296A4
(en)
|
2005-04-29 |
2010-06-30 |
Kosan Biosciences Inc |
METHOD FOR THE TREATMENT OF SEVERAL MYELOMES USING 17-AAG OR 17-AG OR PRODRUGS OR ALL
|
|
CN101198331B
(zh)
*
|
2005-06-13 |
2012-05-02 |
大日本住友制药株式会社 |
增溶化制剂
|
|
EP2548581A3
(en)
*
|
2005-06-17 |
2013-02-20 |
Vital Health Sciences Pty Ltd. |
A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
|
|
WO2007016202A1
(en)
|
2005-07-29 |
2007-02-08 |
Blanchette Rockefeller Neurosciences Institute |
Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
|
|
KR20080033383A
(ko)
*
|
2005-08-12 |
2008-04-16 |
아스트라제네카 아베 |
방법
|
|
ATE538139T1
(de)
*
|
2005-08-30 |
2012-01-15 |
Lanxess Deutschland Gmbh |
Verwendung von katalysatoren für den metatheseabbau von nitrilkautschuk
|
|
WO2007035311A2
(en)
*
|
2005-09-16 |
2007-03-29 |
University Of Massachusetts Lowell |
Anti-oxidant synergy formulation nanoemulsions to treat cancer
|
|
CA2626579A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Abbott Laboratories |
Formulation comprising a drug of low water solubility and method of use thereof
|
|
WO2007056424A2
(en)
*
|
2005-11-07 |
2007-05-18 |
Penwest Pharmaceuticals, Co. |
Controlled-release emulsion compositions
|
|
CN101583620B
(zh)
|
2005-11-28 |
2016-08-17 |
马里纳斯医药公司 |
加奈索酮组合物及其制备和使用方法
|
|
PT1965787E
(pt)
*
|
2005-11-30 |
2013-07-05 |
Endo Pharmaceuticals Inc |
Tratamento de xerostomia com um antioxidante que contém enxofre
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
KR101872061B1
(ko)
*
|
2005-12-19 |
2018-06-27 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
CN101011355B
(zh)
|
2006-02-01 |
2013-01-02 |
陈献 |
经维生素e琥珀酸酯稳定的医药组合物、其制备及用途
|
|
PT1993515E
(pt)
*
|
2006-03-10 |
2009-11-05 |
Laboswiss Ag |
Um método para solubilização, dispersão e estabilização de compostos, produtos obtidos por esse método, assim como a sua utilização
|
|
WO2007124409A2
(en)
|
2006-04-20 |
2007-11-01 |
Velocys, Inc. |
Process for treating and/or forming a non-newtonian fluid using microchannel process technology
|
|
US8112292B2
(en)
|
2006-04-21 |
2012-02-07 |
Medtronic Navigation, Inc. |
Method and apparatus for optimizing a therapy
|
|
KR100917809B1
(ko)
|
2006-05-22 |
2009-09-18 |
에스케이케미칼주식회사 |
우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
|
|
WO2008021368A2
(en)
|
2006-08-11 |
2008-02-21 |
The Johns Hopkins University |
Compositions and methods for neuroprotection
|
|
EA018573B1
(ru)
|
2006-09-22 |
2013-09-30 |
Фармасайкликс, Инк. |
Ингибиторы тирозинкиназы брутона
|
|
US8660635B2
(en)
*
|
2006-09-29 |
2014-02-25 |
Medtronic, Inc. |
Method and apparatus for optimizing a computer assisted surgical procedure
|
|
US8998846B2
(en)
|
2006-11-20 |
2015-04-07 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
|
US8414910B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
|
EP2066321A2
(en)
*
|
2006-11-20 |
2009-06-10 |
Lutonix, Inc. |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
|
US8414909B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
US8414525B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
AU2007325628A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
|
WO2008070538A2
(en)
|
2006-12-01 |
2008-06-12 |
Anterios, Inc. |
Micellar nanoparticles comprising botulinum toxin
|
|
JP5515075B2
(ja)
*
|
2007-01-18 |
2014-06-11 |
国立大学法人 千葉大学 |
微粒子製剤
|
|
CN101605533B
(zh)
*
|
2007-02-09 |
2012-04-18 |
阿斯利康(瑞典)有限公司 |
制备固体非晶亚微米颗粒在水性介质中的稳定分散体的方法
|
|
EP2754448A3
(en)
*
|
2007-02-09 |
2014-12-24 |
Blanchette Rockefeller Neurosciences, Institute |
Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
|
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术（石家庄）有限公司 |
以多西他赛为主组分的新的分散体系
|
|
WO2008106571A2
(en)
*
|
2007-02-28 |
2008-09-04 |
Abbott Laboratories |
Sustained release parenteral formulations of buprenorphine
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
CA2686225A1
(en)
*
|
2007-06-22 |
2008-12-31 |
Scidose Llc |
Solubilized formulation of docetaxel without tween 80
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US8263641B2
(en)
|
2007-09-10 |
2012-09-11 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
AU2008310956B2
(en)
|
2007-10-08 |
2014-08-07 |
Aurinia Pharmaceuticals Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
|
|
US20090130198A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
|
MX2010007076A
(es)
*
|
2007-12-24 |
2010-09-30 |
Sun Pharma Advanced Res Co Ltd |
Nanodispersion.
|
|
US20090176892A1
(en)
*
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
CN101519404B
(zh)
|
2008-02-29 |
2016-01-20 |
唐莉 |
15环噻酮衍生物及其制备方法与应用
|
|
BRPI0909185A2
(pt)
*
|
2008-03-20 |
2015-08-25 |
Virun Inc |
Derivado de vitamina e e seus usos
|
|
BRPI0909187A2
(pt)
|
2008-03-20 |
2015-08-04 |
Virun Inc |
Emulsões incluindo tocoferol de derivados de peg
|
|
DE102008015366A1
(de)
*
|
2008-03-20 |
2009-09-24 |
Merck Patent Gmbh |
Lyophilisierte Nanoemulsion
|
|
US20110038899A1
(en)
*
|
2008-03-28 |
2011-02-17 |
Garry Thomas Gwozdz |
Pharmaceutical Solutions and Method for Solublilizing Therapeutic Agents
|
|
US8409601B2
(en)
|
2008-03-31 |
2013-04-02 |
Cordis Corporation |
Rapamycin coated expandable devices
|
|
US8420110B2
(en)
*
|
2008-03-31 |
2013-04-16 |
Cordis Corporation |
Drug coated expandable devices
|
|
EP2300451A1
(en)
|
2008-06-02 |
2011-03-30 |
Cedars-Sinai Medical Center |
Nanometer-sized prodrugs of nsaids
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
WO2010009075A1
(en)
*
|
2008-07-14 |
2010-01-21 |
The University Of North Carolina At Chapel Hill |
Methods and compositions comprising crystalline nanoparticles of hydrophobic compounds
|
|
FR2933871B1
(fr)
*
|
2008-07-18 |
2012-12-14 |
Yvery |
Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
|
|
EP2321303B1
(en)
|
2008-08-27 |
2019-11-27 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2010024898A2
(en)
|
2008-08-29 |
2010-03-04 |
Lutonix, Inc. |
Methods and apparatuses for coating balloon catheters
|
|
US9676744B2
(en)
|
2008-09-19 |
2017-06-13 |
Purdue Research Foundation |
Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
|
|
CA2737607A1
(en)
*
|
2008-09-19 |
2010-03-25 |
Richard Anthony Gibbs |
Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
|
|
US8165658B2
(en)
*
|
2008-09-26 |
2012-04-24 |
Medtronic, Inc. |
Method and apparatus for positioning a guide relative to a base
|
|
US20140105822A1
(en)
*
|
2008-11-24 |
2014-04-17 |
Cedars-Sinai Medical Center |
Nanospheres comprising tocopherol, an amphiphilic spacer and a therapeutic or imaging agent
|
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
|
JP5339980B2
(ja)
*
|
2009-03-23 |
2013-11-13 |
富士フイルム株式会社 |
分散組成物及び分散組成物の製造方法
|
|
MX338355B
(es)
*
|
2009-06-09 |
2016-04-13 |
Aurinia Pharmaceuticals Inc |
Sistemas de suministro de farmaco topico para uso oftalmico.
|
|
KR20120050414A
(ko)
|
2009-06-19 |
2012-05-18 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
약물의 나노분산액 및 그의 제조 방법
|
|
WO2011043980A1
(en)
|
2009-10-07 |
2011-04-14 |
Sanford Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
|
CN102101863B
(zh)
|
2009-12-17 |
2014-10-15 |
唐莉 |
新型环氧噻酮化合物及其制备方法和用途
|
|
US20110166214A1
(en)
|
2010-01-07 |
2011-07-07 |
Innopharma, Llc |
Methods and compositions for delivery of taxanes in stable oil-in-water emulsions
|
|
AU2011213557B2
(en)
|
2010-02-05 |
2015-05-07 |
Phosphagenics Limited |
Carrier comprising non-neutralised tocopheryl phosphate
|
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前－乳劑調配物及其製造與使用之方法
|
|
KR101622441B1
(ko)
*
|
2010-03-23 |
2016-05-18 |
버런, 아이엔씨. |
자당 지방산 에스테르를 포함하는 나노에멀전
|
|
AU2011232341B2
(en)
*
|
2010-03-26 |
2014-05-01 |
Onconova Therapeutics, Inc. |
Improved stable aqueous formulation of (E)-4-carboxystyryl-4-chlorobenzyl sulfone
|
|
MX2012011355A
(es)
|
2010-03-30 |
2012-11-30 |
Phosphagenics Ltd |
Parche de suministro transdermico.
|
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
|
WO2011133520A1
(en)
|
2010-04-19 |
2011-10-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
WO2011139489A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
JP2013525448A
(ja)
|
2010-04-27 |
2013-06-20 |
カルシメディカ，インク． |
細胞内カルシウムを調節する化合物
|
|
SG185389A1
(en)
|
2010-05-03 |
2012-12-28 |
Teikoku Pharma Usa Inc |
Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
|
|
EP2568999B1
(en)
|
2010-05-11 |
2018-07-11 |
Mallinckrodt Ard Ip Limited |
Acth for treatment of amyotrophic lateral sclerosis
|
|
US20130172333A1
(en)
*
|
2010-05-20 |
2013-07-04 |
Synta Pharmaceuticals Corp. |
Formulation and dosing of hsp90 inhibitory compounds
|
|
CA3007787C
(en)
|
2010-06-03 |
2020-03-10 |
Pharmacyclics Llc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
|
WO2011162802A1
(en)
|
2010-06-21 |
2011-12-29 |
Virun, Inc. |
Compositions containing non-polar compounds
|
|
AU2011293201B2
(en)
|
2010-08-27 |
2015-11-05 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
|
JP5868414B2
(ja)
*
|
2010-11-08 |
2016-02-24 |
カディラ ファーマシューティカルズ リミテッド |
タキソイドの医薬組成物
|
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
|
CA2826506C
(en)
*
|
2011-02-04 |
2017-07-25 |
Biocopea Limited |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
|
WO2012122586A1
(en)
|
2011-03-15 |
2012-09-20 |
Phosphagenics Limited |
New composition
|
|
WO2013067165A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with platinum-containing agents
|
|
JP2014532712A
(ja)
|
2011-11-02 |
2014-12-08 |
シンタ ファーマシューティカルズ コーポレーション |
トポイソメラーゼｉ阻害剤とｈｓｐ９０阻害剤の組合せを使用する癌療法
|
|
US9717678B2
(en)
*
|
2011-11-06 |
2017-08-01 |
Murty Pharmaceuticals, Inc. |
Delivery systems for improving oral bioavailability of Fenobam, its hydrates, and salts
|
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
EP2811847B1
(en)
|
2012-02-10 |
2017-12-13 |
Virun, Inc. |
Beverage compositions containing non-polar compounds
|
|
US20130226550A1
(en)
*
|
2012-02-23 |
2013-08-29 |
Hassan Benameur |
Systems and methods for modeling compound formulations
|
|
ES2905368T3
(es)
|
2012-05-21 |
2022-04-08 |
Insmed Inc |
Sistemas para el tratamiento de infecciones pulmonares
|
|
AR091857A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
|
AR091858A1
(es)
|
2012-07-25 |
2015-03-04 |
Sova Pharmaceuticals Inc |
INHIBIDORES DE CISTATIONIN-g-LIASA (CSE)
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2014085526A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
NZ709368A
(en)
*
|
2012-12-21 |
2020-01-31 |
National Health Res Inst |
Mesoporous silica nanoparticles for oil absorption
|
|
JP6122646B2
(ja)
*
|
2013-01-23 |
2017-04-26 |
昭和電工株式会社 |
皮膚外用剤
|
|
WO2014153221A2
(en)
|
2013-03-14 |
2014-09-25 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of acute respiratory distress syndrome
|
|
US9351517B2
(en)
|
2013-03-15 |
2016-05-31 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and compositions containing same
|
|
US20140314672A1
(en)
*
|
2013-04-06 |
2014-10-23 |
Igdrasol, Inc. |
Nanoparticle therapeutic agents, their formulations, and methods of their use
|
|
US9585417B2
(en)
*
|
2013-06-20 |
2017-03-07 |
Vitasome Labs, Inc. |
Dietary supplement compositions with enhanced delivery matrix, and methods of making the same
|
|
US11044923B2
(en)
|
2013-06-20 |
2021-06-29 |
Vitasome Labs, Inc. |
Gummies containing formulations with enhanced delivery matrix, and methods of making same
|
|
US12256756B2
(en)
|
2013-06-20 |
2025-03-25 |
Vitasome Labs LLC. |
Gummies containing formulations with enhanced delivery matrix, and methods of making same
|
|
US10299492B2
(en)
*
|
2013-06-20 |
2019-05-28 |
James John YIANNIOS |
Dietary supplement compositions with enhanced delivery matrix, gummies, chocolates, atomizers and powders containing same, and methods of making same
|
|
US9693574B2
(en)
|
2013-08-08 |
2017-07-04 |
Virun, Inc. |
Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
|
|
US9896403B2
(en)
*
|
2014-08-22 |
2018-02-20 |
Ironstone Separations, Inc. |
Solubilization of pterostilbene and resveratrol in aqueous beverages
|
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
|
PL3142643T3
(pl)
|
2014-05-15 |
2019-12-31 |
Insmed Incorporated |
Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
|
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
|
US9861611B2
(en)
|
2014-09-18 |
2018-01-09 |
Virun, Inc. |
Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
|
|
US10016363B2
(en)
|
2014-09-18 |
2018-07-10 |
Virun, Inc. |
Pre-spray emulsions and powders containing non-polar compounds
|
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
MY182652A
(en)
*
|
2014-11-25 |
2021-01-27 |
Kl Kepong Oleomas Sdn Bhd |
Formulation for effective tocotrienol delivery
|
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
|
AU2016225026A1
(en)
|
2015-02-27 |
2017-09-07 |
Canopy Growth Corporation |
Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
|
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
|
EP3274548A4
(en)
*
|
2015-03-23 |
2019-01-16 |
President and Fellows of Harvard College |
METHOD AND COMPOSITIONS FOR INJECTING HIGHLY CONCENTRATED AND / OR HIGH VISICULAR ACTIVE SOLUTIONS
|
|
US20160361322A1
(en)
|
2015-06-15 |
2016-12-15 |
Lipocine Inc. |
Composition and method for oral delivery of androgen prodrugs
|
|
EP3331495B1
(en)
|
2015-08-03 |
2020-11-04 |
Tolmar International Limited |
Liquid polymer delivery system for extended administration of drugs
|
|
HK1256718A1
(zh)
|
2015-08-31 |
2019-10-04 |
药品循环有限责任公司 |
用於治疗多发性骨髓瘤的btk抑制剂组合
|
|
TWI752750B
(zh)
|
2015-09-30 |
2022-01-11 |
香港商慧源香港創新有限公司 |
口服紫杉烷組合物及方法
|
|
EP3368543B1
(en)
|
2015-10-26 |
2020-09-23 |
MAX Biopharma, Inc. |
Oxysterols and hedgehog signaling
|
|
US9637514B1
(en)
|
2015-10-26 |
2017-05-02 |
MAX BioPharma, Inc. |
Oxysterols and hedgehog signaling
|
|
CN114712308A
(zh)
*
|
2015-12-09 |
2022-07-08 |
磷肌酸有限公司 |
药物制剂
|
|
WO2017119928A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Abon Pharmaceuticals, Llc |
Long acting injectable formulations
|
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
CA3054674A1
(en)
|
2016-04-04 |
2017-12-10 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using trapidil
|
|
CA3024556A1
(en)
|
2016-05-12 |
2017-11-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
|
EP3463576A4
(en)
|
2016-05-25 |
2020-01-15 |
Concentric Analgesics, Inc. |
PRODRUGS BY PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL ANESTHETIC AND VASOCONSTRICTORS FOR IMPROVED LOCAL ANESTHESIA
|
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
US11242323B2
(en)
|
2016-08-26 |
2022-02-08 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
|
US12485129B2
(en)
|
2016-08-29 |
2025-12-02 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
US10568865B2
(en)
*
|
2016-08-29 |
2020-02-25 |
Canopy Growth Corporation |
Water soluble compositions comprising purified cannabinoids
|
|
JP2019535829A
(ja)
|
2016-11-21 |
2019-12-12 |
エイリオン セラピューティクス， インコーポレイテッド |
大型薬剤の経皮送達
|
|
US11559530B2
(en)
|
2016-11-28 |
2023-01-24 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
|
EP3558903B1
(en)
|
2016-12-21 |
2024-07-03 |
Avecho Biotechnology Limited |
Process for phosphorylating a complex alcohol
|
|
WO2018129345A1
(en)
|
2017-01-08 |
2018-07-12 |
Resq Pharma, Inc. |
Methods for decreasing injuries associated with intraoperative hypotension
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
CN112739345A
(zh)
|
2017-11-06 |
2021-04-30 |
斯奈普生物公司 |
Pim激酶抑制剂组合物，方法和其用途
|
|
JP2021502388A
(ja)
|
2017-11-10 |
2021-01-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ａｓｈ１ｌ阻害剤及びそれを用いた治療方法
|
|
WO2019113469A1
(en)
|
2017-12-07 |
2019-06-13 |
The Regents Of The University Of Michigan |
Nsd family inhibitors and methods of treatment therewith
|
|
EP3508562A1
(en)
*
|
2018-01-05 |
2019-07-10 |
Castrol Limited |
Micellar emulsions
|
|
US11685722B2
(en)
|
2018-02-28 |
2023-06-27 |
Curtana Pharmaceuticals, Inc. |
Inhibition of Olig2 activity
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
HRP20231367T1
(hr)
|
2018-04-30 |
2024-02-16 |
Cedars-Sinai Medical Center |
Postupci i sustavi za odabir i liječenje pacijenata sa upalnim bolestima
|
|
AU2019262117C1
(en)
|
2018-05-02 |
2024-12-05 |
Insmed Incorporated |
Methods for the manufacture of liposomal drug formulations
|
|
WO2019227043A1
(en)
*
|
2018-05-25 |
2019-11-28 |
Resq Pharma, Inc. |
Pre-filled syringe kit
|
|
US11319302B2
(en)
|
2018-06-07 |
2022-05-03 |
The Regents Of The University Of Michigan |
PRC1 inhibitors and methods of treatment therewith
|
|
WO2020010139A1
(en)
|
2018-07-06 |
2020-01-09 |
Cedars-Sinai Medical Center |
Methods of treating refractory inflammatory disease using transcriptomic and genetic risk signatures
|
|
EP3824296A4
(en)
|
2018-07-20 |
2022-04-27 |
Lipocine Inc. |
LIVER DISEASE
|
|
CA3107433A1
(en)
|
2018-07-27 |
2020-01-30 |
Concentric Analgesics, Inc. |
Pegylated prodrugs of phenolic trpv1 agonists
|
|
WO2020046466A1
(en)
|
2018-08-29 |
2020-03-05 |
Myos Rens Technology, Inc. |
Methods for alleviating, inhibiting or reversing muscle disuse atrophy in mammals
|
|
IL281614B2
(en)
|
2018-09-20 |
2024-12-01 |
Blacksmith Medicines Inc |
Antibacterial compounds
|
|
TW202027725A
(zh)
*
|
2018-09-25 |
2020-08-01 |
愛爾蘭商托爾瑪國際有限公司 |
供藥物之延長投予之液體聚合物輸送系統
|
|
US12251405B2
(en)
|
2018-10-03 |
2025-03-18 |
Myos Corp. |
Spray dried follistatin product
|
|
WO2020096660A1
(en)
|
2018-11-06 |
2020-05-14 |
Myos Rens Technology, Inc. |
Methods and compositions for improving skeletal muscle protein fractional synthetic rate
|
|
EP4483870B1
(en)
|
2018-11-26 |
2026-02-18 |
Orphanix GmbH |
Aqueous retinol formulations
|
|
CA3121162A1
(en)
|
2018-11-29 |
2020-06-04 |
Cedars-Sinai Medical Center |
Rnaset2 compositions and methods of treatment therewith
|
|
WO2020135920A1
(en)
*
|
2018-12-28 |
2020-07-02 |
Université Libre de Bruxelles |
Kit for inhaled chemotherapy, and treatment of lung cancer with said kit
|
|
EA202191852A1
(ru)
|
2018-12-31 |
2022-03-18 |
Биомеа Фьюжн, Ллс |
Необратимые ингибиторы взаимодействия менин-mll
|
|
US11833186B2
(en)
|
2019-02-01 |
2023-12-05 |
Myos Corp. |
Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
|
|
SG11202109899VA
(en)
|
2019-03-15 |
2021-10-28 |
Unicycive Therapeutics Inc |
Nicorandil derivatives
|
|
WO2020232125A1
(en)
|
2019-05-14 |
2020-11-19 |
Prometheus Biosciences, Inc. |
Tl1a patient selection methods, systems, and devices
|
|
CA3144267A1
(en)
|
2019-06-21 |
2020-12-24 |
Entelexo Biotherapeutics Inc. |
Platforms, compositions, and methods for therapeutics delivery
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
US20210315902A1
(en)
*
|
2020-03-25 |
2021-10-14 |
Forge Therapeutics, Inc. |
Lpxc inhibitor, formulations, and uses thereof
|
|
CN121550230A
(zh)
|
2020-03-26 |
2026-02-24 |
希诺皮亚生物科学公司 |
同位素标记的曲匹地尔衍生物
|
|
EP4162076A4
(en)
|
2020-06-03 |
2024-10-02 |
Cedars-Sinai Medical Center |
TREATMENTS FOR A SUBPOPULATION OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
|
|
US11717490B2
(en)
*
|
2020-06-05 |
2023-08-08 |
University Of Cyprus |
Therapeutic nanocarrier system and methods of use
|
|
CN116113406B
(zh)
|
2020-07-10 |
2025-08-29 |
密歇根大学董事会 |
Gas41抑制剂及其使用方法
|
|
MX2023003298A
(es)
*
|
2020-09-22 |
2023-08-07 |
Micronization Tech And Therapeutics Group Llc |
Nebulizador y antivirales nebulizados.
|
|
WO2022133064A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
|
AU2022325861A1
(en)
|
2021-08-11 |
2024-02-29 |
Biomea Fusion, Inc. |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
|
US20240409558A1
(en)
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
JP2024536864A
(ja)
|
2021-09-28 |
2024-10-08 |
ブラックスミス メディシンズ，インク． |
Ｌｐｘｃ阻害剤およびその使用
|
|
US20250066386A1
(en)
|
2021-11-09 |
2025-02-27 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
|
JP2025502748A
(ja)
|
2021-12-30 |
2025-01-28 |
バイオメア フュージョン，インコーポレイテッド |
Ｆｌｔ３の阻害剤としてのピラジン化合物
|
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
EP4604978A2
(en)
|
2022-10-19 |
2025-08-27 |
Myos Corp. |
Myogenic compounds
|
|
US20250002458A1
(en)
|
2023-05-24 |
2025-01-02 |
Unicycive Therapeutics Inc. |
Salt forms of nicorandil derivative
|
|
WO2024249950A1
(en)
|
2023-06-02 |
2024-12-05 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
US20250145571A1
(en)
|
2023-09-26 |
2025-05-08 |
Unicycive Therapeutics, Inc. |
Amino acid prodrugs of nicorandil
|
|
WO2025194102A1
(en)
|
2024-03-15 |
2025-09-18 |
Unicycive Therapeutics, Inc. |
Pyridine modified nicorandil derivatives
|
|
US20250304572A1
(en)
|
2024-03-29 |
2025-10-02 |
Biomea Fusion, Inc. |
Heterocyclic glp-1r agonists
|